Cite
HARVARD Citation
Bicer, M. et al. (2017). Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome. Endocrine research. pp. 145-153. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bicer, M. et al. (2017). Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome. Endocrine research. pp. 145-153. [Online].